Cargando…

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Reinhold, Dirk, Brocke, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837106/ https://www.ncbi.nlm.nih.gov/pubmed/33349484 http://dx.doi.org/10.1016/j.clnu.2020.12.005

Ejemplares similares

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Boron enhances the antiviral activity of the curcumin against SARS-CoV-2
por: Scorei, Ion Romulus, et al.
Publicado: (2020)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

DPP4-directed therapeutic strategies for MERS-CoV
por: Reinhold, Dirk, et al.
Publicado: (2014)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Can the host immune response against SARS-CoV2 also cause an anticancer effect?
por: Kahraman, Seda, et al.
Publicado: (2021)

Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity
por: Johnson, Sarah, et al.
Publicado: (2023)

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
por: Favresse, Julien, et al.
Publicado: (2023)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
por: Wolfgruber, Stella, et al.
Publicado: (2023)

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury
por: Vavougios, George D.
Publicado: (2020)

Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy
por: Finsterer, Josef
Publicado: (2022)

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
por: Lu, Jing, et al.
Publicado: (2020)

Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2021)

SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
por: Kirchner, Theresa, et al.
Publicado: (2021)

SARS‐CoV‐2 infection and treatment in a cohort of patients with inborn errors of immunity
por: Conti, Francesca, et al.
Publicado: (2022)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
por: Vasileiou, Spyridoula, et al.
Publicado: (2022)

Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19
por: Martín-Vicente, María, et al.
Publicado: (2022)

Asymptomatic transmission of SARS‐CoV‐2 and implications for mass gatherings
por: Wong, Justin, et al.
Publicado: (2020)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_boolskisjak9bnirs7067mvah3